Nickel Industries Ltd (NIC)
Australian Securities Exchange · Australia · prices in AUD · close of 19 Oct 2026
Key indicators
| Last close | AUD 0.680 |
|---|---|
| 52-week range | 0.660 – 1.125 |
| Return, 1 month / 3 months | −12.3% / −22.3% |
| Return, 1 year / 3 years | −4.9% / −3.3% |
| Trend | Below its 200-day average |
| RSI (14) | 28 |
| Volatility (1 year) | 42.2% |
| Worst drawdown (1 year) | -38.2% |
| Average daily value traded | 5.71M AUD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Nickel Industries is an Australian company that produces nickel in Indonesia. It operates laterite ore mines and smelting facilities that turn ore into nickel pig iron and nickel matte. Its customers are mainly stainless steel producers and battery material makers that need nickel feedstock. The company is based in Australia and runs its mining and processing operations through Indonesian projects, where it holds interests in several smelters and ore sources.
Nickel Industries Ltd trades under the code NIC on the Australian Securities Exchange in Australia, with its price quoted in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Nickel Industries Ltd (NIC) trades on the Australian Securities Exchange in Australia. It last closed at AUD 0.680 on 19 October 2026.
Its price-based Market X-Ray is 59 out of 100 (a fair price profile), ranking 681 of 1,815 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 4.9% and over the last three months it fell 22.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 42 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -25.5% | ||
| From 52-week high | -38.2% | ||
| Momentum | 42 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -22.3% | ||
| 6-month return | -31.3% | ||
| 12-month return, skipping the last month | 8.4% | ||
| Stability (higher is calmer) | 76 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 42.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -38.2% | ||
| Liquidity | 89 · Strong | Trades actively. | |
| Average daily value traded | 5.71M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −8.1% |
|---|---|
| 1 month | −12.3% |
| 3 months | −22.3% |
| 6 months | −31.3% |
| 1 year | −4.9% |
| 3 years | −3.3% |
| 5 years | −24.4% |
Signals
| 50-day / 200-day average | 0.804 / 0.913 |
|---|---|
| Golden / death cross (60 days) | Death, 48 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.029 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 Feb 2025 | AUD 0.0150 |
| 3 Sep 2024 | AUD 0.0250 |
| 2 Feb 2024 | AUD 0.0250 |
| 3 Aug 2023 | AUD 0.0200 |
| 6 Mar 2023 | AUD 0.0200 |
| 6 Sep 2022 | AUD 0.0200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.